{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-006162","form_type":"8-K","ticker":"DMAC","cik":"0001401040","company_name":"DiaMedica Therapeutics Inc.","filed_at":"2022-03-14T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.297811+00:00","generated_at":"2026-06-26T23:08:29.465790+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"DiaMedica reports 2021 results: $45M cash, Phase 2/3 stroke trial underway","bullets":["Cash, cash equivalents and marketable securities $45.1M as of Dec 31, 2021; runway into 2024.","R&D expenses $8.8M for 2021 vs $8.2M prior year; net cash used in operations $12.3M.","Pivotal Phase 2/3 ReMEDy2 trial for DM199 in acute ischemic stroke dosing patients; interim analysis planned after ~140 patients.","Appointed Kirsten Gruis as CMO and Dom Cundari as CCO; last patient dosed in Phase 2 CKD REDUX trial.","No revenue reported; net loss for 2021 not explicitly given but reflected in increased cash used."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-006162","json":"https://secwatch.observer/filing/0001437749-22-006162.json","markdown":"https://secwatch.observer/filing/0001437749-22-006162.md","text":"https://secwatch.observer/filing/0001437749-22-006162.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401040/000143774922006162/0001437749-22-006162-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401040/000143774922006162/dmtp20220310_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T23:08:29.465790+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}